Term ends Oct 21, 2029 · High confidence
20-year base term ends Jan 25, 2027
Held by Biolase MG LLC
Filed Oct 15, 2009 as application 12/579,890 · Granted Jul 1, 2014
Base term plus 1000 days of patent term adjustment (USPTO delay)
Today
2007
2029
Clock starts
Jan 25, 2007
Jan 25, 2007
Term ends
Oct 21, 2029
Oct 21, 2029
Granted
Jul 1, 2014
Jul 1, 2014
base term
patent term adjustment
fee events
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
1,000
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
41
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 1000 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 25, 2007, when application 11/698,345, the earliest non-provisional in its chain, was filed (this one was filed Oct 15, 2009) | Jan 25, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1000 days, USPTO patent term adjustment record | Oct 21, 2029 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 21, 2029 | High confidence |
Partial family
| Application PCT/US1998/012836 | PCT application no patent term | no patent term |
| US 6,616,451 | Term ended Aug 2020 | Aug 2020 |
| US 7,261,558 | Term ended no later than May 2019 | no later than May 2019 |
| US 7,878,204 | Lapsed on the fee record Feb 2023 | Feb 2023 |
| US 7,665,467 | Lapsed on the fee record Feb 2022 | Feb 2022 |
| US 9,101,377 | In force Jan 2028 | Jan 2028 |
| US 7,695,469 | In force Apr 2027 | Apr 2027 |
| US 7,815,630 | In force Jul 2027 | Jul 2027 |
8 of 41 applications in this family shown, earliest filings first. Partial: 2 of the 41 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 5, 2010 Reel 23736, frame 720 | Boutoussov, Dmitri; Atlas, Mikhail | Biolase Technology, Inc. | Assignment of Assignor's Interest |
| Aug 28, 2010 Reel 24900, frame 550 | Biolase Technology, Inc. | Midcap Financial, LLC, as Agent and as a Lender | Security Agreement |
| Sep 30, 2010 Reel 25066, frame 488 | Biolase Technology, Inc.; BL Acquisition Corp.; BL Acquisition II Inc. | Henry Schein, Inc. | Security Agreement |
| May 16, 2011 Reel 26285, frame 666 | Midcap Financial, LLC, Agent and as Lender | Biolase Technology, Inc. | Security Agreement Payoff |
| May 9, 2012 Reel 28184, frame 218 | Henry Schein, Inc. | Biolase Technology, Inc.; BL Acquistion Corp.; BL Acquisition II Inc. | Release of Security Interest |
| May 9, 2012 reel/frame not recorded | Henry Schein, Inc. | Biolase Technology, Inc. | Release of Security Interest |
| May 9, 2012 reel/frame not recorded | Henry Schein, Inc. | BL Acquistion Corp. | Release of Security Interest |
| May 9, 2012 reel/frame not recorded | Henry Schein, Inc. | BL Acquisition II Inc. | Release of Security Interest |
| Nov 20, 2012 Reel 29328, frame 96 | Biolase Technology, Inc. | Biolase, Inc. | Change of Name |
| Mar 7, 2018 Reel 45514, frame 540 | Biolase, Inc. | Western Alliance Bank | Security Interest |
| Nov 10, 2018 Reel 48101, frame 27 | Western Alliance Bank | Biolase, Inc. | Release of Security Interest |
| Nov 16, 2018 Reel 47588, frame 192 | Biolase, Inc. | SWK Funding LLC, as Agent | Security Interest |
| Oct 30, 2019 Reel 50879, frame 223 | Biolase, Inc. | Pacific Mercantile Bank | Security Interest |
| Dec 17, 2024 Reel 69715, frame 613 | Biolase, Inc.; BL Acquisition Corp.; BL Acquisition II, Inc. | Biolase MG LLC | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Oct 2029
Term ends Oct 21, 2029. No further fees fall due before then
Note
The 1000 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
15
later US patents cite this one
That is above the median of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.